Alpha Profiles · Company Profile

Propanc Biopharma, Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/propanc-biopharma-inc

Entity: Public listing published
Primary listing: NASDAQ: PPCB
Verification: Partially verified
Last reviewed: 2026-11-12T04:47:50.336527+00:00

Overview

Alpha's canonical identity and public leadership record for Propanc Biopharma, Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

3 public records

James Nathanielsz

Chief Executive Officer, and Director

State: confirmed
Effective: From Sep 29, 2025
Confidence: 94%
Evidence: PPCB 10-K executive officersSep 29, 2025

Jeannine Zimmerman

Chief Financial Officer

State: confirmed
Effective: From Sep 29, 2025
Confidence: 94%
Evidence: PPCB 10-K executive officersSep 29, 2025

Professor Klaus Kutz

Acting Chief Medical Officer

State: confirmed
Effective: From Sep 29, 2025
Confidence: 94%
Evidence: PPCB 10-K executive officersSep 29, 2025

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Nov 12, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.

Board roles

0 public records

Board roster coverage is NOT_ASSERTED. An empty list is not evidence that this company has no board.

Source record

Alpha canonical company public projection

Supports Company identity, Published leadership, Entity status boundary

Reviewed 2026-11-12T04:47:50.336527+00:00